secwatch.observer — SEC 8-K summary
======================================

Issuer:     EVOME MEDICAL TECHNOLOGIES INC. (—)
CIK:        0001617765
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001062993-24-001870
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evome Medical CFO resigns; reduces acquisition debt by $535K, appoints interim CFO
--------------------------------------------------------------------------------

- CFO Natalia Vakhitova resigned Jan 22, 2024; no disagreement stated. Cherine Pottinger-Harris appointed interim CFO effective Jan 30.
- Sold Arrowhead Medical, reducing acquisition bank debt by $535,093; intercompany debt reduced $209,171.
- Promoted Carmine Tronolone to GM of Biodex Production; Bill Hauer appointed VP Marketing & Sales.
- Preparing to launch SpaceTek Knee (co-developed with NASA) and Reactive Step Trainer in 2024.
- Granted 460,000 stock options to three executives, vesting over 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617765/000106299324001870/0001062993-24-001870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617765/000106299324001870/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-24-001870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer